Screener
AOCI at other companies
Other financials
Where this comes from
Reported directly by Johnson & Johnson in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The source filing: Johnson & Johnson’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000200406-26-000153
| Line item | June 28, 2026 | December 28, 2025 |
|---|---|---|
| Commitments and Contingencies (Note 11) | ||
| Shareholders’ equity: | ||
| Common stock — par value $1.00 per share (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) | $3,120 | 3,120 |
| Accumulated other comprehensive income (loss) (Note 7) | (13,951) | (14,930) |
| Retained earnings and Additional paid-in capital | 171,665 | 168,978 |
| Less: common stock held in treasury, at cost (711,615,000 and 711,904,000 shares) | 75,863 | 75,624 |
| Total shareholders’ equity | $84,971 | 81,544 |
| Total liabilities and shareholders’ equity | $201,061 | 199,210 |
Item 1 — Financial statements
FAQ
- What is Johnson & Johnson's AOCI?
- Johnson & Johnson (JNJ) reported AOCI of -$13.95B in Q2 2026.
- How has Johnson & Johnson's AOCI changed year-over-year?
- Johnson & Johnson's AOCI increased by 2.5% year-over-year, from -$14.31B to -$13.95B.
- What is the long-term trend for Johnson & Johnson's AOCI?
- Over 5 years (2020 to 2025), Johnson & Johnson's AOCI has grown at a -0.4% compound annual growth rate (CAGR), from -$15.24B to -$14.93B.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.
Ask your AI about Johnson & Johnson's aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude